Related references
Note: Only part of the references are listed.Systematic Review and Meta-analysis on the Effects of Thiopurines on Birth Outcomes from Female and Male Patients with Inflammatory Bowel Disease
Mona Akbari et al.
INFLAMMATORY BOWEL DISEASES (2013)
Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study
Jessica Coelho et al.
GUT (2011)
The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD)
Lisa Shim et al.
JOURNAL OF CROHNS & COLITIS (2011)
The transfer of 6-mercaptopurine in the dually perfused human placenta
J. R. Hutson et al.
REPRODUCTIVE TOXICOLOGY (2011)
Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes
Hyunyoung Jeong
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Limited stability of thiopurine metabolites in blood samples: Relevant in research and clinical practise
P. de Graaf et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
Relapses of inflammatory bowel disease during pregnancy: In-hospital management and birth outcomes
Deepa Reddy et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
Azathioprine use during pregnancy: Unexpected intrauterine exposure to metabolites
NKH de Boer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Increasing incidences of inflammatory bowel disease and decreasing surgery rates in copenhagen city and county, 2003-2005: A population-based study from the Danish crohn colitis database
Ida Vind et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy
T Dervieux et al.
CLINICAL CHEMISTRY (2005)
Differences in nucleotide hydrolysis contribute to the differences between erythrocyte 6-thioguanine nucleotide concentrations determined by two widely used methods
M Shipkova et al.
CLINICAL CHEMISTRY (2003)
The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: A retrospective cohort study
A Francella et al.
GASTROENTEROLOGY (2003)
Teratogen update: Azathioprine and 6-mercaptopurine
JE Polifka et al.
TERATOLOGY (2002)
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease
MC Dubinsky et al.
GASTROENTEROLOGY (2002)
Share Paper
